Screener
Monte Rosa Therapeutics, Inc. GLUE Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s asset turnover?
- Monte Rosa Therapeutics, Inc. (GLUE) reported asset turnover of 0.1× in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s asset turnover changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s asset turnover decreased by 89.2% year-over-year, from 0.5× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Monte Rosa Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude